Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 3Endocrine 3Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1CNS 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Melanoma 15Head and Neck Neoplasms 15Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 8Uterine Cervical Neoplasms 7Neoplasms 7Colorectal Neoplasms 7Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Carcinoma, Merkel Cell 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Kidney Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Esophageal Neoplasms 3Urogenital Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Gastrointestinal Neoplasms 2

Interventions

Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3FAPI-46 2tislelizumab 1surufatinib 1romidepsin 1repotrectinib 1pralsetinib 1pembrolizumab 1fludarabine phosphate 1entrectinib 1cabozantinib 1atezolizumab 1alectinib 1Specimen Handling 1Quality of Life 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Lactones 1Interleukin-2 1Interleukin-13 1Immunotherapy 1Drug Therapy 1Depsipeptides 1Cyclophosphamide 1Cryosurgery 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroendocrine Tumors × atezolizumab × Head & Neck × Clear all
NCT04400474 2025-06-19

CABATEN

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed
93 enrolled 17 charts
CNSEndocrineHead & NeckNET

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡